Virology Specimen Collection Market size is estimated to be valued at USD 5,287.3 Million in 2021 and is poised to grow at a significant CAGR of 4.8% over 2022-2028. The process of collecting samples for laboratory analysis or near-patient testing is known as specimen collection. The vitals and reagents needed in collecting samples and delivering them to the laboratory where testing services will be done are included in the sample collection kit. The virology transport media segment is anticipated to grow at a significant CAGR over the forecast years owing to the viral transport media are essential kits that contain transport media in a tube as well as a swab, and rising awareness of people for donating blood. Due to the significant number of people that are donating blood, the need for virology transport is increasing. Moreover, the market players are focusing on launching new products, collaboration, and acquisitions to maintain growth in the forecasting market. For instance, In June 2020, BD announced the CE Mark and market launch of the BD Vacutainer Ultra Touch Blood collection set. The increasing prevalence of viral diseases, the rising prevalence of human papillomavirus (HPV) and cervical cancer, and the growing number of blood donations are a few factors driving the global virology specimen collection market growth over the forecasting period.
Recent Market Developments:
In June 2020, BD American multinational medical technology company announced the CE Mark and market launch of the BD Vacutainer UltraTouch Blood collection set.
In September 2020, Thermo Scientific company launched the Thermo Scientific SpeciMAX Stabilized Saliva Collection Kit.